Cargando…
Inhibition of TRIM32 Induced by miR-519d Increases the Sensitivity of Colorectal Cancer Cells to Cisplatin
BACKGROUND: Colorectal cancer is a leading cause of cancer-related death in the world. Despite cisplatin is a commonly used chemotherapeutic drug for the colorectal cancer treatment, resistance of cancer cells to cisplatin restricts its clinical efficacy. It is important to explore the potential mec...
Autores principales: | Su, Xueliang, Wang, Bangjie, Wang, Yehong, Wang, Baochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968806/ https://www.ncbi.nlm.nih.gov/pubmed/32021274 http://dx.doi.org/10.2147/OTT.S235940 |
Ejemplares similares
-
MiR-519d and miR-328-3p Combinatorially Suppress Breast Cancer Progression
por: Ma, Haiming, et al.
Publicado: (2020) -
MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1
por: Xie, Qing, et al.
Publicado: (2017) -
HCP5 Promotes Proliferation and Contributes to Cisplatin Resistance in Gastric Cancer Through miR-519d/HMGA1 Axis
por: Zhang, Zhu, et al.
Publicado: (2021) -
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC
por: Fornari, Francesca, et al.
Publicado: (2015) -
miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin
por: Yao, Huixiang, et al.
Publicado: (2019)